Blog Archives

Reducing patterns of brain hyperactivity in individuals at genetic risk of Alzheimer’s disease: an important avenue for early-life risk reduction?

By Dr Claire Lancaster Fifty million people live with dementia worldwide, the most common cause of which is Alzheimer’s – a progressive, neurodegenerative disease. Although the past 12-months have seen Aducanumab expediated for FDA approval – the first new drug

Tagged with: , , ,
Posted in Faculty research

Alzheimer type dementia

by Prof Jennifer Rusted Age is not synonymous with poor health, but Alzheimer type dementia (AD) is a disease of the brain for which age is the biggest risk factor – the older you are, the greater your risk of

Tagged with: , , ,
Posted in Faculty research

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.